Latest News Releases From The Newsroom
Momentum Surge: Elafibranor's PBC Trial Data Boosts Genfit
June 30th, 2023
Ipsen S.A. (OTCMKTS: IPSEY) and Genfit S.A. (Nasdaq: GNFT) have announced positive results from the ELATIVE Phase III trial evaluating elafibranor as a treatment for patients with primary biliary cholangitis (PBC), a rare cholestatic liver disease, w. Read more
Supreme Court's Decision Sparks Biden's Call for Inclusive Education
June 30th, 2023
President Biden has announced a series of actions aimed at promoting educational opportunity and diversity in colleges and universities. The recent Supreme Court's decision in two cases — Students for Fair Admissions Inc. (SFFA) v. President an. Read more
Breaking: Renalytix's KidneyIntelX.dkd FDA-Approved, VSE Secures Up to $565M Contract
June 29th, 2023
Shares of Renalytix plc (Nasdaq: RNLX) surged over 25% in after-hours trading following the company's announcement of receiving De Novo marketing authorization from the U.S. Food and Drug Administration (FDA) for its KidneyIntelX.dkd prognostic test.. Read more
Surging and Slumping: Aurinia Pharmaceuticals and Root Make Headlines
June 29th, 2023
Shares of Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH) witnessed a significant surge of over 10% in after-hours trading, driven by the company's announcement of initiating an exploration of strategic alternatives. The Board of Aurinia will carefull. Read more
Earnings Buzz and Reactions: Accolade, Progress Software, and Nike
June 29th, 2023
Accolade, Inc. (Nasdaq: ACCD) released its first-quarter fiscal 2024 earnings report, revealing a loss of $0.52 per share, which was better than the consensus estimate of a loss of $0.62 per share. The company also reported quarterly sales of $93.20 . Read more
SEC Charges Former Pfizer Statistician with Insider Trading Ahead of COVID-19 Announcement
June 29th, 2023
Employee and friend traded ahead of Pfizer’s “game-changer” announcement on the success of its Paxlovid trial FOR IMMEDIATE RELEASE 2022-123 Washington D.C. / CRWE PRESS RELEASE / June 29, 2023 - The Securities and Exch. Read more
BREAKING: BioXcel's Regulatory Inquiry Status Sends Shares Tumbling
June 29th, 2023
Shares of BioXcel Therapeutics, Inc.? (Nasdaq: BTAI) plunged by over 50% in premarket trading following the company's disclosure of a regulatory inquiry into the development of BXCL501, as revealed in a regulatory filing with the SEC. Despite this. Read more
Joby's Pre-Market Surge, Nano Dimension's Milestone Quarter: What You Need to Know
June 29th, 2023
Shares of Joby Aviation, Inc. (NYSE: JOBY) experienced a significant surge of over 10% in pre-market trading following the announcement of an equity investment by SK Telecom Co., Ltd.? (NYSE: SKM), a prominent telecommunications company in South Kore. Read more
Earnings Beat: BlackBerry, Greenbrier, and Acuity Brands in the Spotlight
June 29th, 2023
Shares of BlackBerry Limited (NYSE: BB) experienced a significant surge of over 10% in pre-market trading following the release of better-than-expected financial results. The company delivered a surprise profit for the first quarter of fiscal 2024. Read more
Bullishness: ZI, GPC, SQSP, DE, VVI, WIX, ARRY, GDDY - Top Buy Ratings
June 29th, 2023
ZoomInfo Technologies Inc. (Nasdaq: ZI), a leading provider of go-to-market intelligence solutions, received coverage initiation from Needham with a Buy rating and a price target of $35. Despite closing at $25.61 on Wednesday, the stated pri. Read more
Member Login